Effect of apical hyperosmotic sodium challenge and amiloride on sodium transport in human bronchial epithelial cells from cystic fibrosis donors
Hypertonic saline (HS) inhalation therapy benefits cystic fibrosis (CF) patients [Donaldson SH, Bennet WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. N Engl J Med 354: 241-250, 2006; Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, Belousova EG, Xuan W, Bye PT; the National Hyperto...
Gespeichert in:
Veröffentlicht in: | American Journal of Physiology: Cell Physiology 2013-12, Vol.305 (11), p.C1114-C1122 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | C1122 |
---|---|
container_issue | 11 |
container_start_page | C1114 |
container_title | American Journal of Physiology: Cell Physiology |
container_volume | 305 |
creator | Rasgado-Flores, Hector Krishna Mandava, Vamsi Siman, Homayoun Van Driessche, Willy Pilewski, Joseph M Randell, Scott H Bridges, Robert J |
description | Hypertonic saline (HS) inhalation therapy benefits cystic fibrosis (CF) patients [Donaldson SH, Bennet WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. N Engl J Med 354: 241-250, 2006; Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, Belousova EG, Xuan W, Bye PT; the National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group. N Engl J Med 354: 229-240, 2006]. Surprisingly, these benefits are long-lasting and are diminished by the epithelial Na(+) channel blocker amiloride (Donaldson SH, Bennet WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. N Engl J Med 354: 241-250, 2006). Our aim was to explain these effects. Human bronchial epithelial (hBE) cells from CF lungs were grown in inserts and were used in three experimental approaches: 1) Ussing chambers to measure amiloride-sensitive short-circuit currents (INa); 2) continuous perfusion Ussing chambers; and 3) near "thin-film" conditions in which the airway surface of the inserts was exposed to a small volume (30 μl) of isosmotic or HS solution as the inserts were kept in their incubation tray and were subsequently used to measure INa under isosmotic conditions (near thin-film experiments; Tarran R, Boucher RC. Methods Mol Med 70: 479-492, 2002). HS solutions (660 mosmol/kgH2O) were prepared by adding additional NaCl to the isosmotic buffer. The transepithelial short-circuit current (ISC), conductance (GT), and capacitance (CT) were measured by transepithelial impedance analysis (Danahay H, Atherton HC, Jackson AD, Kreindler JL, Poll CT, Bridges RJ. Am J Physiol Lung Cell Mol Physiol 290: L558-L569, 2006; Singh AK, Singh S, Devor DC, Frizzell RA, van Driessche W, Bridges RJ. Methods Mol Med 70: 129-142, 2002). Exposure to apical HS inhibited INa, GT, and CT. The INa inhibition required 60 min of reexposure to the isosmotic solution to recover 75%. The time of exposure to HS required to inhibit INa was |
doi_str_mv | 10.1152/ajpcell.00166.2013 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3882386</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3158648091</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-d334e8ac3e54db88825beaafd0aba005fddba419fa1a5f3b391c7136ee35a6163</originalsourceid><addsrcrecordid>eNpdkc1u1TAQhS0EopfCC7BAltiwycXOOL7JBglV5UeqxAbW1sQ_ja8SO9gJ0n2LPjIOva2AlS3NN2fmzCHkNWd7zpv6PR5nbcdxzxiXcl8zDk_IrhTqijcSnpIdAwmV5AIuyIucj4wxUcvuObmooWsl7w47cnftnNULjY7i7DWOdDjNNsU8xcVrmqPx60T1gONow62lGAzFyY8xeWNpDA_EkjDkOaaF-kCHdcJA-xSDHnyRtLNfBjtu323hTF2KRfSUtxHOFzD7TE0MMeWX5JnDMdtX5_eS_Ph0_f3qS3Xz7fPXq483lRbAlsoACNuiBtsI07dtWze9RXSGYY-MNc6YHgXvHHJsHPTQcX3gIK2FBiWXcEk-3OvOaz9Zo20oFkY1Jz9hOqmIXv1bCX5Qt_GXgjIL2k3g3VkgxZ-rzYuafN7sYbBxzYoLKUR3AMEL-vY_9BjXFIq9jWoPvO5aKFR9T-lyj5yse1yGM7UFrs6Bqz-Bqy3w0vTmbxuPLQ8Jw2-OMa3F</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1468712983</pqid></control><display><type>article</type><title>Effect of apical hyperosmotic sodium challenge and amiloride on sodium transport in human bronchial epithelial cells from cystic fibrosis donors</title><source>MEDLINE</source><source>American Physiological Society</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Rasgado-Flores, Hector ; Krishna Mandava, Vamsi ; Siman, Homayoun ; Van Driessche, Willy ; Pilewski, Joseph M ; Randell, Scott H ; Bridges, Robert J</creator><creatorcontrib>Rasgado-Flores, Hector ; Krishna Mandava, Vamsi ; Siman, Homayoun ; Van Driessche, Willy ; Pilewski, Joseph M ; Randell, Scott H ; Bridges, Robert J</creatorcontrib><description>Hypertonic saline (HS) inhalation therapy benefits cystic fibrosis (CF) patients [Donaldson SH, Bennet WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. N Engl J Med 354: 241-250, 2006; Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, Belousova EG, Xuan W, Bye PT; the National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group. N Engl J Med 354: 229-240, 2006]. Surprisingly, these benefits are long-lasting and are diminished by the epithelial Na(+) channel blocker amiloride (Donaldson SH, Bennet WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. N Engl J Med 354: 241-250, 2006). Our aim was to explain these effects. Human bronchial epithelial (hBE) cells from CF lungs were grown in inserts and were used in three experimental approaches: 1) Ussing chambers to measure amiloride-sensitive short-circuit currents (INa); 2) continuous perfusion Ussing chambers; and 3) near "thin-film" conditions in which the airway surface of the inserts was exposed to a small volume (30 μl) of isosmotic or HS solution as the inserts were kept in their incubation tray and were subsequently used to measure INa under isosmotic conditions (near thin-film experiments; Tarran R, Boucher RC. Methods Mol Med 70: 479-492, 2002). HS solutions (660 mosmol/kgH2O) were prepared by adding additional NaCl to the isosmotic buffer. The transepithelial short-circuit current (ISC), conductance (GT), and capacitance (CT) were measured by transepithelial impedance analysis (Danahay H, Atherton HC, Jackson AD, Kreindler JL, Poll CT, Bridges RJ. Am J Physiol Lung Cell Mol Physiol 290: L558-L569, 2006; Singh AK, Singh S, Devor DC, Frizzell RA, van Driessche W, Bridges RJ. Methods Mol Med 70: 129-142, 2002). Exposure to apical HS inhibited INa, GT, and CT. The INa inhibition required 60 min of reexposure to the isosmotic solution to recover 75%. The time of exposure to HS required to inhibit INa was <2.5 min. Under near thin-film conditions, apical exposure to HS inhibited INa, but as osmotically driven water moved to the apical surface, the aqueous apical volume increased, leading to an amiloride-insensitive decrease in its osmolality and to recovery of INa that lagged behind the osmotic recovery. Amiloride significantly accelerated the recovery of INa following exposure to HS. Our conclusions are that exposure to HS inhibits hBE INa and that amiloride diminishes this effect.</description><identifier>ISSN: 0363-6143</identifier><identifier>EISSN: 1522-1563</identifier><identifier>DOI: 10.1152/ajpcell.00166.2013</identifier><identifier>PMID: 23986197</identifier><identifier>CODEN: AJPCDD</identifier><language>eng</language><publisher>United States: American Physiological Society</publisher><subject>Airway management ; Amiloride - administration & dosage ; Bronchi - drug effects ; Bronchi - metabolism ; Bronchi - pathology ; Cell Culture Techniques - methods ; Cells ; Cells, Cultured ; Cystic fibrosis ; Cystic Fibrosis - drug therapy ; Cystic Fibrosis - metabolism ; Humans ; Ion Transport - drug effects ; Ion Transport - physiology ; Lungs ; Osmosis ; Respiratory Mucosa - drug effects ; Respiratory Mucosa - metabolism ; Respiratory Mucosa - pathology ; Saline Solution, Hypertonic - administration & dosage ; Sodium - metabolism ; Thin films</subject><ispartof>American Journal of Physiology: Cell Physiology, 2013-12, Vol.305 (11), p.C1114-C1122</ispartof><rights>Copyright American Physiological Society Dec 1, 2013</rights><rights>Copyright © 2013 the American Physiological Society 2013 American Physiological Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-d334e8ac3e54db88825beaafd0aba005fddba419fa1a5f3b391c7136ee35a6163</citedby><cites>FETCH-LOGICAL-c430t-d334e8ac3e54db88825beaafd0aba005fddba419fa1a5f3b391c7136ee35a6163</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,781,785,886,3040,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23986197$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rasgado-Flores, Hector</creatorcontrib><creatorcontrib>Krishna Mandava, Vamsi</creatorcontrib><creatorcontrib>Siman, Homayoun</creatorcontrib><creatorcontrib>Van Driessche, Willy</creatorcontrib><creatorcontrib>Pilewski, Joseph M</creatorcontrib><creatorcontrib>Randell, Scott H</creatorcontrib><creatorcontrib>Bridges, Robert J</creatorcontrib><title>Effect of apical hyperosmotic sodium challenge and amiloride on sodium transport in human bronchial epithelial cells from cystic fibrosis donors</title><title>American Journal of Physiology: Cell Physiology</title><addtitle>Am J Physiol Cell Physiol</addtitle><description>Hypertonic saline (HS) inhalation therapy benefits cystic fibrosis (CF) patients [Donaldson SH, Bennet WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. N Engl J Med 354: 241-250, 2006; Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, Belousova EG, Xuan W, Bye PT; the National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group. N Engl J Med 354: 229-240, 2006]. Surprisingly, these benefits are long-lasting and are diminished by the epithelial Na(+) channel blocker amiloride (Donaldson SH, Bennet WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. N Engl J Med 354: 241-250, 2006). Our aim was to explain these effects. Human bronchial epithelial (hBE) cells from CF lungs were grown in inserts and were used in three experimental approaches: 1) Ussing chambers to measure amiloride-sensitive short-circuit currents (INa); 2) continuous perfusion Ussing chambers; and 3) near "thin-film" conditions in which the airway surface of the inserts was exposed to a small volume (30 μl) of isosmotic or HS solution as the inserts were kept in their incubation tray and were subsequently used to measure INa under isosmotic conditions (near thin-film experiments; Tarran R, Boucher RC. Methods Mol Med 70: 479-492, 2002). HS solutions (660 mosmol/kgH2O) were prepared by adding additional NaCl to the isosmotic buffer. The transepithelial short-circuit current (ISC), conductance (GT), and capacitance (CT) were measured by transepithelial impedance analysis (Danahay H, Atherton HC, Jackson AD, Kreindler JL, Poll CT, Bridges RJ. Am J Physiol Lung Cell Mol Physiol 290: L558-L569, 2006; Singh AK, Singh S, Devor DC, Frizzell RA, van Driessche W, Bridges RJ. Methods Mol Med 70: 129-142, 2002). Exposure to apical HS inhibited INa, GT, and CT. The INa inhibition required 60 min of reexposure to the isosmotic solution to recover 75%. The time of exposure to HS required to inhibit INa was <2.5 min. Under near thin-film conditions, apical exposure to HS inhibited INa, but as osmotically driven water moved to the apical surface, the aqueous apical volume increased, leading to an amiloride-insensitive decrease in its osmolality and to recovery of INa that lagged behind the osmotic recovery. Amiloride significantly accelerated the recovery of INa following exposure to HS. Our conclusions are that exposure to HS inhibits hBE INa and that amiloride diminishes this effect.</description><subject>Airway management</subject><subject>Amiloride - administration & dosage</subject><subject>Bronchi - drug effects</subject><subject>Bronchi - metabolism</subject><subject>Bronchi - pathology</subject><subject>Cell Culture Techniques - methods</subject><subject>Cells</subject><subject>Cells, Cultured</subject><subject>Cystic fibrosis</subject><subject>Cystic Fibrosis - drug therapy</subject><subject>Cystic Fibrosis - metabolism</subject><subject>Humans</subject><subject>Ion Transport - drug effects</subject><subject>Ion Transport - physiology</subject><subject>Lungs</subject><subject>Osmosis</subject><subject>Respiratory Mucosa - drug effects</subject><subject>Respiratory Mucosa - metabolism</subject><subject>Respiratory Mucosa - pathology</subject><subject>Saline Solution, Hypertonic - administration & dosage</subject><subject>Sodium - metabolism</subject><subject>Thin films</subject><issn>0363-6143</issn><issn>1522-1563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkc1u1TAQhS0EopfCC7BAltiwycXOOL7JBglV5UeqxAbW1sQ_ja8SO9gJ0n2LPjIOva2AlS3NN2fmzCHkNWd7zpv6PR5nbcdxzxiXcl8zDk_IrhTqijcSnpIdAwmV5AIuyIucj4wxUcvuObmooWsl7w47cnftnNULjY7i7DWOdDjNNsU8xcVrmqPx60T1gONow62lGAzFyY8xeWNpDA_EkjDkOaaF-kCHdcJA-xSDHnyRtLNfBjtu323hTF2KRfSUtxHOFzD7TE0MMeWX5JnDMdtX5_eS_Ph0_f3qS3Xz7fPXq483lRbAlsoACNuiBtsI07dtWze9RXSGYY-MNc6YHgXvHHJsHPTQcX3gIK2FBiWXcEk-3OvOaz9Zo20oFkY1Jz9hOqmIXv1bCX5Qt_GXgjIL2k3g3VkgxZ-rzYuafN7sYbBxzYoLKUR3AMEL-vY_9BjXFIq9jWoPvO5aKFR9T-lyj5yse1yGM7UFrs6Bqz-Bqy3w0vTmbxuPLQ8Jw2-OMa3F</recordid><startdate>20131201</startdate><enddate>20131201</enddate><creator>Rasgado-Flores, Hector</creator><creator>Krishna Mandava, Vamsi</creator><creator>Siman, Homayoun</creator><creator>Van Driessche, Willy</creator><creator>Pilewski, Joseph M</creator><creator>Randell, Scott H</creator><creator>Bridges, Robert J</creator><general>American Physiological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20131201</creationdate><title>Effect of apical hyperosmotic sodium challenge and amiloride on sodium transport in human bronchial epithelial cells from cystic fibrosis donors</title><author>Rasgado-Flores, Hector ; Krishna Mandava, Vamsi ; Siman, Homayoun ; Van Driessche, Willy ; Pilewski, Joseph M ; Randell, Scott H ; Bridges, Robert J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-d334e8ac3e54db88825beaafd0aba005fddba419fa1a5f3b391c7136ee35a6163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Airway management</topic><topic>Amiloride - administration & dosage</topic><topic>Bronchi - drug effects</topic><topic>Bronchi - metabolism</topic><topic>Bronchi - pathology</topic><topic>Cell Culture Techniques - methods</topic><topic>Cells</topic><topic>Cells, Cultured</topic><topic>Cystic fibrosis</topic><topic>Cystic Fibrosis - drug therapy</topic><topic>Cystic Fibrosis - metabolism</topic><topic>Humans</topic><topic>Ion Transport - drug effects</topic><topic>Ion Transport - physiology</topic><topic>Lungs</topic><topic>Osmosis</topic><topic>Respiratory Mucosa - drug effects</topic><topic>Respiratory Mucosa - metabolism</topic><topic>Respiratory Mucosa - pathology</topic><topic>Saline Solution, Hypertonic - administration & dosage</topic><topic>Sodium - metabolism</topic><topic>Thin films</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rasgado-Flores, Hector</creatorcontrib><creatorcontrib>Krishna Mandava, Vamsi</creatorcontrib><creatorcontrib>Siman, Homayoun</creatorcontrib><creatorcontrib>Van Driessche, Willy</creatorcontrib><creatorcontrib>Pilewski, Joseph M</creatorcontrib><creatorcontrib>Randell, Scott H</creatorcontrib><creatorcontrib>Bridges, Robert J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Physical Education Index</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American Journal of Physiology: Cell Physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rasgado-Flores, Hector</au><au>Krishna Mandava, Vamsi</au><au>Siman, Homayoun</au><au>Van Driessche, Willy</au><au>Pilewski, Joseph M</au><au>Randell, Scott H</au><au>Bridges, Robert J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of apical hyperosmotic sodium challenge and amiloride on sodium transport in human bronchial epithelial cells from cystic fibrosis donors</atitle><jtitle>American Journal of Physiology: Cell Physiology</jtitle><addtitle>Am J Physiol Cell Physiol</addtitle><date>2013-12-01</date><risdate>2013</risdate><volume>305</volume><issue>11</issue><spage>C1114</spage><epage>C1122</epage><pages>C1114-C1122</pages><issn>0363-6143</issn><eissn>1522-1563</eissn><coden>AJPCDD</coden><abstract>Hypertonic saline (HS) inhalation therapy benefits cystic fibrosis (CF) patients [Donaldson SH, Bennet WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. N Engl J Med 354: 241-250, 2006; Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, Belousova EG, Xuan W, Bye PT; the National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group. N Engl J Med 354: 229-240, 2006]. Surprisingly, these benefits are long-lasting and are diminished by the epithelial Na(+) channel blocker amiloride (Donaldson SH, Bennet WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. N Engl J Med 354: 241-250, 2006). Our aim was to explain these effects. Human bronchial epithelial (hBE) cells from CF lungs were grown in inserts and were used in three experimental approaches: 1) Ussing chambers to measure amiloride-sensitive short-circuit currents (INa); 2) continuous perfusion Ussing chambers; and 3) near "thin-film" conditions in which the airway surface of the inserts was exposed to a small volume (30 μl) of isosmotic or HS solution as the inserts were kept in their incubation tray and were subsequently used to measure INa under isosmotic conditions (near thin-film experiments; Tarran R, Boucher RC. Methods Mol Med 70: 479-492, 2002). HS solutions (660 mosmol/kgH2O) were prepared by adding additional NaCl to the isosmotic buffer. The transepithelial short-circuit current (ISC), conductance (GT), and capacitance (CT) were measured by transepithelial impedance analysis (Danahay H, Atherton HC, Jackson AD, Kreindler JL, Poll CT, Bridges RJ. Am J Physiol Lung Cell Mol Physiol 290: L558-L569, 2006; Singh AK, Singh S, Devor DC, Frizzell RA, van Driessche W, Bridges RJ. Methods Mol Med 70: 129-142, 2002). Exposure to apical HS inhibited INa, GT, and CT. The INa inhibition required 60 min of reexposure to the isosmotic solution to recover 75%. The time of exposure to HS required to inhibit INa was <2.5 min. Under near thin-film conditions, apical exposure to HS inhibited INa, but as osmotically driven water moved to the apical surface, the aqueous apical volume increased, leading to an amiloride-insensitive decrease in its osmolality and to recovery of INa that lagged behind the osmotic recovery. Amiloride significantly accelerated the recovery of INa following exposure to HS. Our conclusions are that exposure to HS inhibits hBE INa and that amiloride diminishes this effect.</abstract><cop>United States</cop><pub>American Physiological Society</pub><pmid>23986197</pmid><doi>10.1152/ajpcell.00166.2013</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0363-6143 |
ispartof | American Journal of Physiology: Cell Physiology, 2013-12, Vol.305 (11), p.C1114-C1122 |
issn | 0363-6143 1522-1563 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3882386 |
source | MEDLINE; American Physiological Society; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Airway management Amiloride - administration & dosage Bronchi - drug effects Bronchi - metabolism Bronchi - pathology Cell Culture Techniques - methods Cells Cells, Cultured Cystic fibrosis Cystic Fibrosis - drug therapy Cystic Fibrosis - metabolism Humans Ion Transport - drug effects Ion Transport - physiology Lungs Osmosis Respiratory Mucosa - drug effects Respiratory Mucosa - metabolism Respiratory Mucosa - pathology Saline Solution, Hypertonic - administration & dosage Sodium - metabolism Thin films |
title | Effect of apical hyperosmotic sodium challenge and amiloride on sodium transport in human bronchial epithelial cells from cystic fibrosis donors |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T17%3A51%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20apical%20hyperosmotic%20sodium%20challenge%20and%20amiloride%20on%20sodium%20transport%20in%20human%20bronchial%20epithelial%20cells%20from%20cystic%20fibrosis%20donors&rft.jtitle=American%20Journal%20of%20Physiology:%20Cell%20Physiology&rft.au=Rasgado-Flores,%20Hector&rft.date=2013-12-01&rft.volume=305&rft.issue=11&rft.spage=C1114&rft.epage=C1122&rft.pages=C1114-C1122&rft.issn=0363-6143&rft.eissn=1522-1563&rft.coden=AJPCDD&rft_id=info:doi/10.1152/ajpcell.00166.2013&rft_dat=%3Cproquest_pubme%3E3158648091%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1468712983&rft_id=info:pmid/23986197&rfr_iscdi=true |